- Location
2
results for "
Digestive Care
"-
Cornerstone Therapeutics Has Signed an Agreement to Acquire Exclusive US Marketing Rights
May 14, 2013Cornerstone Therapeutics has signed an agreement to acquire exclusive US marketing rights to Pertzye (pancrelipase) from Digestive Care (DCI). Pertzye, the pancreatic enzyme product, is indicated for the treatment of exocrine pancreatic ...
Tags: Cornerstone, Digestive Care
-
DCI Has Gained FDA Approval for Its New Drug Application (NDA) for Pertzye
May 21, 2012Digestive Care (DCI) has gained FDA approval for its new drug application (NDA) for Pertzye, a pancreatic enzyme product containing bicarbonate-buffered enteric-coated microspheres. Pertzye is indicated for the treatment of Exocrine ...
Related Products
-
High Potency Lecithin Softgel Capsule Non-GMO Lecithin Soybean Phosphatidylcholine for Prenatel Health
-
Bifidobacterium Lactis Bl-G101 200 Billion
-
Bifidobacterium Lactis Bl-G101 300 Billion
-
Bifidobacterium Lactis Bl-G101 500 Billion
-
Bifidobacterium Lactis Bl-G101 100 Billion
-
Bifidobacterium Lactis Bl-G101 400 Billion
